Norbert Arnold

13.2k citations

202 papers · 10.6k · 3 hit papers · h-index 52

Impact in

Genetics top 0.2%
- BRCA gene mutations in cancer
- Genetic Associations and Epidemiology
- Genomic variations and chromosomal abnormalities
Cancer Research top 1%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies

Papers in

Genetics 108
- BRCA gene mutations in cancer 97
- Genomic variations and chromosomal abnormalities 5
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 4
Reproductive Medicine 18
- Ovarian cancer diagnosis and treatment 18

Co-authors: Marion Kiechle (27 shared papers)W. Jonat (22 shared papers)Johannes Wienberg (10 shared papers)Alfons Meindl (19 shared papers)Ulrike Schwarz‐Boeger (5 shared papers)Roscoe Stanyon (6 shared papers)Eva Groß (7 shared papers)Dieter Niederacher (19 shared papers)
Journals: Human Mutation (11 papers)Breast Cancer Research (10 papers)International Journal of Cancer (9 papers)Archives of Gynecology and Obstetrics (8 papers)Genes Chromosomes and Cancer (7 papers)
Partner nations: Germany United Kingdom United States

In The Last Decade

Norbert Arnold

197 papers receiving 10.3k citations

Norbert Arnold's Hit Papers

align trajectories log scale

Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer 2015 · 406 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2015 JAMA
2013 Nature Genetics
2012 Cancer Epidemiology Biomarkers & Prevention

Peers

Countries citing papers authored by Norbert Arnold

Since Specialization

Citations

This map shows the geographic impact of Norbert Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Arnold more than expected).

Fields of papers citing papers by Norbert Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Arnold. The network helps show where Norbert Arnold may publish in the future.

Co-authors

The 25 scholars most cited alongside Norbert Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norbert Arnold Line = papers co-authored together Norbert Arnold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Cancer Epidemiology Biomarkers & Prevention ·Nasim Mavaddat, Daniel Barrowdale, Irene Louise Andrulis, Susan M. Domchek, Diana Eccles, Heli A. Nevanlinna, Susan J. Ramus, Amanda B. Spurdle Hit paper breakdown →	2012	538
2	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Nature Genetics ·Australian Cancer Study, Stig E. Bojesen, Australian Ovarian Cancer Study, Gene Environment Interaction and Breast Cancer (GENICA), Swedish Breast Cancer Study (SWE-BRCA), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Karen A. Pooley Hit paper breakdown →	2013	468
3	Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer JAMA ·Timothy Richard Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue C. Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench Hit paper breakdown →	2015	406
4	Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk PLoS Genetics ·Fergus J. Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Karoline B. Kuchenbaecker, Penny Soucy, Zachary Fredericksen	2013	331
5	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Nature Genetics ·Roger Laughlin Milne, Karoline B. Kuchenbaecker, K Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon	2017	306
6	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population Nature Genetics ·Antonis C. Antoniou, Xianshu Wang, Zachary S. Fredericksen, Lesley McGuffog, Robert F. Tarrell, Olga M. Sinilnikova, Sue C. Healey, Christiana Kartsonaki	2010	278
7	Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Journal of Clinical Oncology ·Monika Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G. Froster, Bettina Schlehe	2009	254
8	Reconstruction of genomic rearrangements in great apes and gibbons by chromosome painting. Proceedings of the National Academy of Sciences ·Anna Sophia Jauch, Johannes Wienberg, Roscoe Stanyon, Norbert Arnold, Sergio Tofanelli, Takafumi Ishida, Thomas John Cremer	1992	250
9	Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations Human Mutation ·Timothy Richard Rebbeck, Tara M. Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Oláh, Olufunmilayo Ibironke Olopade	2018	245
10	Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers The American Journal of Human Genetics ·Antonis C. Antoniou, Amanda B. Spurdle, Olga M. Sinilnikova, Sue C. Healey, Karen A. Pooley, Rita Katharina Schmutzler, Beatrix Versmold, Christoph Engel	2008	228
11	RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies The American Journal of Human Genetics ·Antonis C. Antoniou, Olga M. Sinilnikova, Jacques Simard, Mélanie Léoné, Martine Dumont, Susan L. Neuhausen, Jeffery P. Struewing, Dominique Stoppa‐Lyonnet	2007	213
12	A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC Human Genetics ·Norbert Arnold, J. Goette, Ulrike Schwarz‐Boeger, Marion Kiechle +1 other	1999	178
13	Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer PLoS Biology ·Christopher A. Maxwell, Javier Benítez, Laia Gómez‐Baldó, Ana Osório, Núria Bonifaci, Ricardo Fernández‐Ramires, Sylvain V. Costes, Elisabet Guinó	2011	177
14	Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Kölner Universitäts PublikationsServer (Universität zu Köln) ·Shuai Li, Valentina Silvestri, Goska Leslie, Timothy Richard Rebbeck, Susan L. Neuhausen, John Llewelyn Hopper, Henriette Roed Nielsen, Andrew Lee	2021	166
15	Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential Oncogene ·Ivo M. Meinhold-Heerlein, Dirk Bauerschlag, Felix Hilpert, Petre Dimitrov, Lisa M. Sapinoso, Marzenna Orlowska‐Volk, Thomas Bauknecht, Tjoung‐Won Park	2004	165
16	Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer Journal of Medical Genetics ·Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Eric Hahnen, Jan Hauke, Britta Blümcke, Verena Zarghooni, N Herold	2016	165
17	Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction Cancer Research ·Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M. Sinilnikova, Sue C. Healey, Susan L. Neuhausen, Yuan Chun Ding, Timothy Richard Rebbeck	2010	153
18	Evaluation of SNPs inmiR-146a,miR196a2andmiR-499as low-penetrance alleles in German and Italian familial breast cancer cases Human Mutation ·Irene Catucci, Rongxi Yang, Paolo Verderio, Sara Pizzamiglio, Ludwig Heesen, Kari Hemminki, Christian Sutter, Barbara Wappenschmidt	2009	142
19	Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores Journal of Clinical Oncology ·Julie Lecarpentier, Valentina Silvestri, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie	2017	142
20	Gene panel testing of 5589 BRCA 1/2 ‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer Cancer Medicine ·Jan Hauke, Judit E. Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch, Karl Hackmann, Gunnar Schmidt, Norbert Arnold	2018	137

About Norbert Arnold

Norbert Arnold is a scholar working on Genetics, Reproductive Medicine, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 202 papers that have together received 10.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (97 papers), Ovarian cancer diagnosis and treatment (18 papers), Genomic variations and chromosomal abnormalities (5 papers), Breast Cancer Treatment Studies (5 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers), MicroRNA in disease regulation (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Genetics (4.4k citations), Cancer Research (765 citations), Reproductive Medicine (555 citations), Oncology (387 citations) and Molecular Biology (670 citations). Norbert Arnold has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Marion Kiechle, W. Jonat, Johannes Wienberg, Alfons Meindl, Ulrike Schwarz‐Boeger, Roscoe Stanyon, Eva Groß, Dieter Niederacher, Jörg Paul Weimer and Sergio Tofanelli. Their work appears in journals such as Human Mutation, Breast Cancer Research, International Journal of Cancer, Archives of Gynecology and Obstetrics and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Norbert Arnold

Impact in

Papers in i

In The Last Decade

Norbert Arnold

Norbert Arnold's Hit Papers

Peers

Countries citing papers authored by Norbert Arnold

Fields of papers citing papers by Norbert Arnold

All Works

About Norbert Arnold

Explore authors with similar magnitude of impact

Papers in